Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 89 (1), 58-62

Extranodal Multifocal Rosai-Dorfman Disease: Response to 2-chlorodeoxyadenosine Treatment

Affiliations
Case Reports

Extranodal Multifocal Rosai-Dorfman Disease: Response to 2-chlorodeoxyadenosine Treatment

Ceyla Konca et al. Int J Hematol.

Abstract

Rosai-Dorfman disease (RDD) or "sinus histiocytosis with massive lymphadenopathy" is a rare lymphoproliferative disorder of unknown etiology. The disease usually presents with painless lymphadenopathy with occasional extranodal involvement in various organs. We report a case of a 36-year-old man with a history of non-Hodgkin lymphoma (NHL), who recently presented with inguinal lymphadenopathy. Following the diagnosis of RDD on lymph node biopsy, he developed symptoms of spinal cord compression due to a mass lesion discovered at T6-7 vertebral level. 18F-Fluorodeoxyglucose (18FDG) positron emission tomography (PET-CT) revealed extensive disease with lung, renal and bone involvement. The patient received a short course of steroid therapy for cord compression findings and 2-chlorodeoxyadenosine (2-CdA) treatment was initiated for long-term disease control. He had a dramatic sustained response to treatment with six courses of 2-CdA. These results suggest that 2-CdA can be an effective treatment of choice and positron emission tomography with 18FDG can be used for determining the extent of disease and for follow-up in RDD.

Similar articles

See all similar articles

Cited by 10 PubMed Central articles

See all "Cited by" articles

References

    1. J Clin Pathol. 1973 Jul;26(7):463-9 - PubMed
    1. Cancer. 1972 Nov;30(5):1174-88 - PubMed
    1. Arch Dermatol. 2007 Jun;143(6):736-40 - PubMed
    1. Urology. 2005 Dec;66(6):1319 - PubMed
    1. AJNR Am J Neuroradiol. 1996 Feb;17(2):361-3 - PubMed

Publication types

LinkOut - more resources

Feedback